These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31138493)

  • 61. Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases.
    Stein S; Bogard E; Boice N; Fernandez V; Field T; Gilstrap A; Kahn SR; Larkindale J; Mathieson T
    Orphanet J Rare Dis; 2018 Jan; 13(1):18. PubMed ID: 29357903
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Building on a foundation of strong clinical trial data, SCCT advocacy gaining momentum with U.S. payers and stakeholders: Advocacy updates over the past year.
    Thomas DM; Shaw LJ
    J Cardiovasc Comput Tomogr; 2018; 12(6):e24-e25. PubMed ID: 30322773
    [No Abstract]   [Full Text] [Related]  

  • 63. Development and Implementation of the DHAPP Military eHealth Information Network System.
    Kratz M; Thomas A; Hora R; Vera D; Lutz M; Johnson MD
    Curr HIV Res; 2017; 15(2):102-108. PubMed ID: 28521714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain.
    Cheng JS; Lee MJ; Massicotte E; Ashman B; Gruenberg M; Pilcher LE; Skelly AC
    Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S144-63. PubMed ID: 21952186
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy.
    Engelstad K; Sklerov M; Kriger J; Sanford A; Grier J; Ash D; Egli D; DiMauro S; Thompson JL; Sauer MV; Hirano M
    Hum Reprod; 2016 May; 31(5):1058-65. PubMed ID: 26936885
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Building Meaningful Patient Engagement in Research: Case Study From ADVANCE Clinical Data Research Network.
    Warren NT; Gaudino JA; Likumahuwa-Ackman S; Dickerson K; Robbins L; Norman K; Lind J; D'Amato S; Foley P; Gold R; Bauer V; Fields SA; Cohen DJ; Clark KD; DeVoe JE
    Med Care; 2018 Oct; 56 Suppl 10 Suppl 1(10 Suppl 1):S58-S63. PubMed ID: 30074953
    [TBL] [Abstract][Full Text] [Related]  

  • 67. First steps in developing a managed clinical network for vascular services in Lanarkshire.
    Moir D; Campbell H; Wrench J; Miller S
    Health Bull (Edinb); 2001 Nov; 59(6):405-11. PubMed ID: 12661391
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bridging the Gap between Health and Social Care for Rare Diseases: Key Issues and Innovative Solutions.
    Castro R; Senecat J; de Chalendar M; Vajda I; Dan D; Boncz B;
    Adv Exp Med Biol; 2017; 1031():605-627. PubMed ID: 29214594
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recruiting Primary Care Practices for Research: Reflections and Reminders.
    Fernald DH; Jortberg BT; Hessler DM; Wearner R; Dickinson LM; Fisher L; Dickinson WP
    J Am Board Fam Med; 2018; 31(6):947-951. PubMed ID: 30413552
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Diagnostic investigations of mitochondrial diseases with neurological symptoms].
    Auré K; Lombès A
    Rev Neurol (Paris); 2007 Feb; 163(2):254-63. PubMed ID: 17351548
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes.
    Karaa A; Goldstein A
    Pediatr Diabetes; 2015 Feb; 16(1):1-9. PubMed ID: 25330715
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of clinical guidelines for inborn errors of metabolism: commentary.
    Vockley J; Chapman KA; Arnold GL
    Mol Genet Metab; 2013 Apr; 108(4):203-5. PubMed ID: 23428739
    [TBL] [Abstract][Full Text] [Related]  

  • 73. View from inside: Tália's story.
    Bacarese-Hamilton S; Bacarese-Hamilton A
    J Inherit Metab Dis; 2020 Mar; 43(2):161-166. PubMed ID: 31944311
    [No Abstract]   [Full Text] [Related]  

  • 74. Involving patient groups to provide support and information in the care of rare conditions.
    Bennett S; Granerod J; Solomon T
    Nurs Times; 2010 Oct 26-Nov 1; 106(42):21. PubMed ID: 21121450
    [No Abstract]   [Full Text] [Related]  

  • 75. The evolution of the mitochondrial disease diagnostic odyssey.
    Thompson JLP; Karaa A; Pham H; Yeske P; Krischer J; Xiao Y; Long Y; Kramer A; Dimmock D; Holbert A; Gorski C; Engelstad KM; Buchsbaum R; Rosales XQ; Hirano M
    Orphanet J Rare Dis; 2023 Jun; 18(1):157. PubMed ID: 37349818
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Knowledge and awareness of mitochondrial diseases among physicians in the tertiary hospitals in Ghana.
    Mensah EA; Sarfo B; Yawson AE; Arthur J; Ocloo A
    PLoS One; 2022; 17(10):e0276549. PubMed ID: 36264964
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gaining Insight into Mitochondrial Genetic Variation and Downstream Pathophysiology: What Can i(PSCs) Do?
    Moreira JD; Gopal DM; Kotton DN; Fetterman JL
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828274
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary mitochondrial disease in the US: Data from patients and physicians' perspective on health care delivery.
    Karaa A; Goldstein A; Balcells C; Mann K; Stanley L; Yeske PE; Parikh S
    Data Brief; 2019 Aug; 25():104343. PubMed ID: 31516925
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fractal genetics and heterogeneous phenotypes of mitochondrial disease require appropriate logistics of managing network structures.
    Finsterer J
    Mol Genet Metab Rep; 2019 Sep; 20():100492. PubMed ID: 31321208
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.